Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Essential Thrombocythemia

Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
Sep 14, 2026, 07:37 | Science
Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
Joseph Pierre Aboumsallem, Drug Development Lead – siRNA Therapeutics, Postdoctoral Researcher, Project Manager at Erasmus…
Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
Sep 13, 2026, 04:22 | Voices
Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
Gabriela Hobbs, Leukemia Clinical Director at Massachusetts General Hospital, Associate Professor at Harvard Medical School…
The First New Treatment for Essential Thrombocythemia in Nearly 30 Years
Sep 11, 2026, 12:22 | Blog
The First New Treatment for Essential Thrombocythemia in Nearly 30 Years
The treatment landscape of essential thrombocythemia (ET) has changed little for decades. That changed in…
Can Özlü: Can the HALP Score Help Identify Thrombotic Risk in Myeloproliferative Neoplasms?
Sep 9, 2026, 13:07 | Science
Can Özlü: Can the HALP Score Help Identify Thrombotic Risk in Myeloproliferative Neoplasms?
Can Özlü, General Manager at CAS Industrial Health Products Trading Ltd. Co., Associate Professor at…
Kim Cook: Bringing Rare Blood Cancers Into the Conversation
Sep 2, 2026, 15:09 | Voices
Kim Cook: Bringing Rare Blood Cancers Into the Conversation
Kim Cook, Senior Manager of Information Security Risk Management at Instructure, shared a post on…
Faheema Hasan: A New Second-Line Therapy for Essential Thrombocythemia
Sep 2, 2026, 14:07 | Voices
Faheema Hasan: A New Second-Line Therapy for Essential Thrombocythemia
Faheema Hasan, Associate Professor at United Medicity, shared a post on LinkedIn: "FDA Approves Besremi…
Cristina Chang: The Importance of The New ET Treatments
Sep 1, 2026, 08:24 | Voices
Cristina Chang: The Importance of The New ET Treatments
Cristina Chang, Chief Medical Officer (CMO), Global at Harvest Integrated Research Organization (HiRO), shared a…
Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
Aug 31, 2026, 14:28 | Voices
Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
Ruben Mesa, President of Cancer National Service Line at Advocate Health, shared a post on LinkedIn:…
Youssef Afifi: The Thrombocytosis–Bleeding Paradox
Jun 18, 2026, 15:13 | Voices
Youssef Afifi: The Thrombocytosis–Bleeding Paradox
Youssef Afifi, Consultant of Hematology and Internal Medicine at Cleopatra Hospitals Group, Consultant of Hematology and…
Georgiana Toma: From Cytoreduction to Vascular Protection in Essential Thrombocythemia
Mar 21, 2026, 12:47 | Voices
Georgiana Toma: From Cytoreduction to Vascular Protection in Essential Thrombocythemia
Georgiana Toma, Hematology resident at the University Emergency Hospital of Bucharest, shared a post on LinkedIn:…
Lucia Masarova Presents Results of Phase III SURPASS-ET Trial at SOHO 2025: Ropeg's Efficacy for Essential Thrombocythemia
Sep 5, 2025, 12:18 | Science
Lucia Masarova Presents Results of Phase III SURPASS-ET Trial at SOHO 2025: Ropeg's Efficacy for Essential Thrombocythemia
MPN Hub shared on X: ''CONGRESS | SOHO 2025 | POSTER Lucia Masarova, MD Anderson…
SOHO 2025: Gabriela Hobbs on Emerging Strategies for Managing Polycythemia Vera and Essential Thrombocythemia
Sep 4, 2025, 18:00 | Drugs
SOHO 2025: Gabriela Hobbs on Emerging Strategies for Managing Polycythemia Vera and Essential Thrombocythemia
MPN Hub shared on X: ''CONGRESS | SOHO 2025 | PRESENTATION Gabriela Hobbs, Massachusetts General Hospital…
What Drives Essential Thrombocythemia? Dr. William Aird on the Pathophysiology of Platelet Overproduction
Jul 7, 2025, 11:42 | Insight
What Drives Essential Thrombocythemia? Dr. William Aird on the Pathophysiology of Platelet Overproduction
 Dr. William Aird, Professor of Medicine at Harvard Medical School, has posted on X:  “Essential…
All: 13 Posts: 1 - 100
NewsFeed